1. Contemporary transcatheter aortic valve implantation related thrombocytopenia
- Author
-
Jacob George, Dan Haberman, Alexander Maximovskih, Lion Poles, Gera Gandelman, Sara Shimoni, Igor Volodarsky, Michael Jonas, Haitham Abu Khadija, Maher Abu Kweider, Alex Blatt, and Omar Ayyad
- Subjects
Male ,Aortic valve ,medicine.medical_specialty ,Transcatheter aortic ,030204 cardiovascular system & hematology ,Transcatheter Aortic Valve Replacement ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Humans ,Medicine ,Radiology, Nuclear Medicine and imaging ,030212 general & internal medicine ,Symptomatic aortic stenosis ,Aged ,Aged, 80 and over ,business.industry ,Mean age ,Aortic Valve Stenosis ,General Medicine ,Thrombocytopenia ,Treatment Outcome ,Increased risk ,Contrast used ,medicine.anatomical_structure ,Aortic Valve ,embryonic structures ,Cohort ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business ,Major bleeding - Abstract
BACKGROUND Transcatheter aortic valve implantation related thrombocytopenia (TAVI-rTP) is an inevitable phenomenon. However, no study has been performed on TAVI-rTP in the current setting of extended clinical indications combined with technology improvements. METHODS Patients with severe symptomatic aortic stenosis who underwent transfemoral TAVI, from January 2016 to December 2019 were enrolled. RESULTS Two-hundred and one consecutive patients (mean age 81.1 ± 7.1 years, 96 men) enrolled. Platelet count was recorded before and after aortic valve implantation. Dropped platelet count (DPC) occurred in all but 11 patients who were included. Two groups were created: DPC
- Published
- 2020
- Full Text
- View/download PDF